ClinicalTrials.gg
Sign In

Vaginal Neoplasms clinical trials

The registry lists 159 studies for Vaginal Neoplasms across more than 10 countries. 39 are recruiting or about to start. 10 of them are mainly about Vaginal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Vaginal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
84
Recruiting
34
Active, not recruiting
12
Terminated
10
Status unknown
9
Withdrawn
5

Phase

Phase 1
38
Phase 2
35
Phase 3
18
Early Phase 1
1

Where

United States
87
China
17
United Kingdom
11
Canada
7
France
6
Italy
5

Who runs them

M.D. Anderson Cancer Center (11) · Merck Sharp & Dohme LLC (10) · National Cancer Institute (NCI) (10) · Shanghai Bovax Biotechnology Co., Ltd. (7) · Ohio State University Comprehensive Cancer Center (6) · Memorial Sloan Kettering Cancer Center (5) · Royal Marsden NHS Foundation Trust (5) · City of Hope Medical Center (4)

What is being tested here

Drugs under test in Vaginal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Therapeutic Tumor Infiltrating Lymphocytes202
Human Papillomavirus Recombinant Vaccine nonavalent166
Dehydroepiandrosterone112
Becotatug vedotin101
Zimberelimab101
Talazoparib101
Belzutifan101
Triapine013
Cisplatin003
Bevacizumab002

Drug classes tested here Immune checkpoint inhibitors 1 open · Antimetabolites 5 · Angiogenesis inhibitors 4 · Antimitotic agents 3

Coming up

5phase 3 studies under way
16studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 34 Vaginal Neoplasms studies recruiting now, 20 (59%) set no upper age limit and 9 (26%) stop at 75 or younger. 5 (15%) take children under 18. 23 (68%) are for women only and 0 (0%) for men only; 6 (18%) take healthy volunteers.

Recruiting studies that take each age, of 34
AgeWomenMen
105 (15%)1 (3%)
1831 (91%)10 (29%)
3032 (94%)11 (32%)
4032 (94%)11 (32%)
5030 (88%)11 (32%)
6529 (85%)11 (32%)
7528 (82%)10 (29%)
8523 (68%)9 (26%)

Across all 159 studies, recruiting or not: 22% stop at 75 or younger and 17% at 65; 19% take children; 66% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vaginal Neoplasms studies take

Of 13 phase 3 interventional studies under Vaginal Neoplasms, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 320 mo15–26 · 13 studies——
Interventional, no phase27 mo18–82 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 159. Browse all 159 → or search them.